CytoCare™.

CytoCare automates the compounding of hazardous IVs used for chemotherapy, monoclonal antibody therapy, and genetic therapy.  The result:

• Better patient care – Automated compounding improves accuracy, consistency and minimizes manual errors.
• Safer staff – Automation minimizes exposure to hazardous medications resulting from manual handling such as cross contamination, spills, aerosolizing and needle sticks.
• Improved efficiencies – Streamlined workflow and more efficient preparation schedules enable valuable staff to do other critical tasks.

See how much better hazardous IV preparation can be.